BioPredict has developed tools to analyze compound collections to guide purchasing or synthesis decisions.  For our clients, the confidentiality of proprietary structures is maintained by providing BioPredict with compound descriptors rather than with actual compound structures for performing this analysis. In addition to selecting compounds which meet the general requirements of diversity and drug-likeness, BioPredict  brings significant modeling tools and expertise to bear on the design of protein-family or super-family targeted libraries.